Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors and outcome of multidrug-resistant tuberculosis.
Salomon N, Perlman DC, Friedmann P, Buchstein S, Kreiswirth BN, Mildvan D. Salomon N, et al. Among authors: perlman dc. Clin Infect Dis. 1995 Nov;21(5):1245-52. doi: 10.1093/clinids/21.5.1245. Clin Infect Dis. 1995. PMID: 8589150
Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG).
el-Sadr WM, Perlman DC, Matts JP, Nelson ET, Cohn DL, Salomon N, Olibrice M, Medard F, Chirgwin KD, Mildvan D, Jones BE, Telzak EE, Klein O, Heifets L, Hafner R. el-Sadr WM, et al. Among authors: perlman dc. Clin Infect Dis. 1998 May;26(5):1148-58. doi: 10.1086/520275. Clin Infect Dis. 1998. PMID: 9597244 Clinical Trial.
Cytomegalovirus pneumonia.
Salomon N, Perlman DC. Salomon N, et al. Among authors: perlman dc. Semin Respir Infect. 1999 Dec;14(4):353-8. Semin Respir Infect. 1999. PMID: 10638515 Review.
"Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.
Des Jarlais DC, Perlis T, Arasteh K, Hagan H, Milliken J, Braine N, Yancovitz S, Mildvan D, Perlman DC, Maslow C, Friedman SR. Des Jarlais DC, et al. Among authors: perlman dc. J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):158-66. doi: 10.1097/00126334-200402010-00010. J Acquir Immune Defic Syndr. 2004. PMID: 14722449
Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial.
Gross R, Tierney C, Andrade A, Lalama C, Rosenkranz S, Eshleman SH, Flanigan T, Santana J, Salomon N, Reisler R, Wiggins I, Hogg E, Flexner C, Mildvan D; AIDS Clinical Trials Group A5073 Study Team. Gross R, et al. Arch Intern Med. 2009 Jul 13;169(13):1224-32. doi: 10.1001/archinternmed.2009.172. Arch Intern Med. 2009. PMID: 19597072 Free PMC article. Clinical Trial.
Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae.
Nigo M, Cevallos CS, Woods K, Flores VM, Francis G, Perlman DC, Revuelta M, Mildvan D, Waldron M, Gomez T, Koshy S, Jodlowski T, Riley W, Ruhe JJ. Nigo M, et al. Among authors: perlman dc. Antimicrob Agents Chemother. 2013 Nov;57(11):5743-6. doi: 10.1128/AAC.00827-13. Epub 2013 Aug 26. Antimicrob Agents Chemother. 2013. PMID: 23979745 Free PMC article.
174 results